The Future of Clinical Translational Pharmacology.

Creator(s)

• Matthew L. Rizk
• Anuradha Ramamoorthy
• Stephani L. Stancil, Children's Mercy Kansas CityFollow
• Abigail W. Gorman
• Julie A. Johnson
• John A. Wagner
• Issam Zineh
• Sandra A G Visser

Document Type

Article

Publication Date

7-2026

Identifier

DOI: 10.1002/cpt.70281

Abstract

Will clinical translational pharmacology (CTP) seize the opportunity to become a leadership discipline driving the next era of patient-centered therapeutics? This white paper, based on input and discussion from the ASCPT Summit on the Future of Clinical Translational Pharmacology, issues a bold call to action for CTP to define itself as a discipline that embraces its multidisciplinary breadth, demanding a radical shift that visibly inhabits the full scope of its multitudinous identity. We propose a five-priority roadmap-Foundational Principles, Workforce and Leadership, Innovation and Technology, Health Equity and Global Health, and Public Visibility and Scientific Trust-to transform CTP into an engine of therapeutic advancement and optimization. The future of medicine depends on CTP's ability to lead, adapt, influence, and unify across silos, ensuring that scientific breakthroughs translate into real-world benefit for every patient, everywhere. The next decade demands urgency, unity, and unapologetic ambition to move beyond incremental change.

Journal Title

Clinical pharmacology and therapeutics

Volume

120

Issue

1

First Page

36

Last Page

42

MeSH Keywords

Humans; Translational Research, Biomedical; Pharmacology, Clinical; Leadership; Forecasting

PubMed ID

41979204

Keywords

Biomedical Translational Research; Clinical Pharmacology; Leadership; Forecasting

Recommended Citation

Rizk ML, Ramamoorthy A, Stancil SL, et al. The Future of Clinical Translational Pharmacology. Clin Pharmacol Ther. 2026;120(1):36-42. doi:10.1002/cpt.70281